Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
aimmune therapeutics
biotech
2
×
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
fda
glaxosmithkline
2
×
life sciences
national
national blog main
national top stories
2
×
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
vertex pharmaceuticals
2
×
wisconsin blog main
wisconsin top stories
abbvie
advaxis
akcea therapeutics
akebia therapeutics
alder biopharmaceuticals
alex pinto
alexander hardy
amarin pharma
amarna therapeutics
amylyx
amyotrophic lateral sclerosis (als)
What
bio
2
×
bucks
2
×
roundup
abbvie’s
ahead
big
biofourmis
bosley's
bosley’s
bridge
cancer
cas
celebrate
ceo
chance
corner
crime
crispr
day
days
departure
editas
exit
forward
guiding
holiday
katrine
labor
looking
medicine
moves
people
personnel
pharma
summer
surprising
waning
week
Language
unset
Current search:
bucks
×
bio
×
biotech
×
" national top stories "
×
glaxosmithkline
×
" vertex pharmaceuticals "
×
@xconomy.com
4 years ago
Bio Roundup: Pharma M&A, AbbVie’s Cancer Bet, Biofourmis Bucks & More
@xconomy.com
5 years ago
Bio Roundup: Bosley’s Editas Exit, Bridge Bucks, CRISPR Crime & More